The Scientist

» patent, immunology and culture

Most Recent

image: AACR Q&A: Elaine Mardis

AACR Q&A: Elaine Mardis

By | April 18, 2016

The genomics pioneer shares the sessions she most looks forward to at this year’s American Association for Cancer Research annual meeting.

0 Comments

image: Another Gene-Editing IPO

Another Gene-Editing IPO

By | April 12, 2016

Intellia Therapeutics, which seeks to develop CRISPR-based technologies to target rare diseases, is hoping to raise $120 million in an initial public offering.

0 Comments

image: Microglia Tamp Down Neurogenesis

Microglia Tamp Down Neurogenesis

By | April 7, 2016

The immune cells—known for clearing dead cells—also chew up live progenitors in neurogenic regions of mouse brains. 

0 Comments

image: One Way Placenta Deflects Zika Infection

One Way Placenta Deflects Zika Infection

By | April 5, 2016

Certain immune cells surrounding the organ appear to block viral entry.

0 Comments

image: Book Excerpt from <em>The Serengeti Rules</em>

Book Excerpt from The Serengeti Rules

By | April 1, 2016

In the introduction to the book, author Sean B. Carroll draws the parallels between ecological and physiological maladies.

0 Comments

image: Capsule Reviews

Capsule Reviews

By | April 1, 2016

Lab Girl, The Most Perfect Thing, Half-Earth, and Cosmosapiens

0 Comments

image: Guts and Glory

Guts and Glory

By | April 1, 2016

An open mind and collaborative spirit have taken Hans Clevers on a journey from medicine to developmental biology, gastroenterology, cancer, and stem cells.

1 Comment

image: Speaking of Science

Speaking of Science

By | April 1, 2016

April 2016's selection of notable quotes

0 Comments

image: Tumor Traps

Tumor Traps

By | April 1, 2016

After surgery to remove a tumor, neutrophils recruited to the site spit out sticky webs of DNA that aid cancer recurrence.

0 Comments

image: Book Review: <em>Personal Trials</em>

Book Review: Personal Trials

By | March 22, 2016

At first blush, do-it-yourself clinical trials seem pointless and reckless. But a deeper truth pervades the research and the patients who drive it forward.

0 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  4. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

RayBiotech